CLRB
Price
$4.80
Change
+$0.07 (+1.48%)
Updated
Jul 3 closing price
Capitalization
8.7M
43 days until earnings call
NXTC
Price
$0.44
Change
+$0.01 (+2.33%)
Updated
Jul 3 closing price
Capitalization
12.22M
25 days until earnings call
Interact to see
Advertisement

CLRB vs NXTC

Header iconCLRB vs NXTC Comparison
Open Charts CLRB vs NXTCBanner chart's image
Cellectar Biosciences
Price$4.80
Change+$0.07 (+1.48%)
Volume$238.95K
Capitalization8.7M
NextCure
Price$0.44
Change+$0.01 (+2.33%)
Volume$86.06K
Capitalization12.22M
CLRB vs NXTC Comparison Chart in %
Loading...
CLRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLRB vs. NXTC commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLRB is a Hold and NXTC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (CLRB: $4.73 vs. NXTC: $0.44)
Brand notoriety: CLRB and NXTC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLRB: 5% vs. NXTC: 38%
Market capitalization -- CLRB: $8.7M vs. NXTC: $12.22M
CLRB [@Biotechnology] is valued at $8.7M. NXTC’s [@Biotechnology] market capitalization is $12.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLRB’s FA Score shows that 0 FA rating(s) are green whileNXTC’s FA Score has 1 green FA rating(s).

  • CLRB’s FA Score: 0 green, 5 red.
  • NXTC’s FA Score: 1 green, 4 red.
According to our system of comparison, NXTC is a better buy in the long-term than CLRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLRB’s TA Score shows that 4 TA indicator(s) are bullish while NXTC’s TA Score has 3 bullish TA indicator(s).

  • CLRB’s TA Score: 4 bullish, 6 bearish.
  • NXTC’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, CLRB is a better buy in the short-term than NXTC.

Price Growth

CLRB (@Biotechnology) experienced а -35.91% price change this week, while NXTC (@Biotechnology) price change was -5.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

CLRB is expected to report earnings on Aug 18, 2025.

NXTC is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NXTC($12.2M) has a higher market cap than CLRB($8.7M). NXTC YTD gains are higher at: -43.476 vs. CLRB (-47.269). CLRB has less debt than NXTC: CLRB (474K) vs NXTC (4.91M).
CLRBNXTCCLRB / NXTC
Capitalization8.7M12.2M71%
EBITDAN/A-50.34M-
Gain YTD-47.269-43.476109%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A55.9M-
Total Debt474K4.91M10%
FUNDAMENTALS RATINGS
CLRB vs NXTC: Fundamental Ratings
CLRB
NXTC
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
12
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9665
P/E GROWTH RATING
1..100
78100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NXTC's Valuation (12) in the Biotechnology industry is somewhat better than the same rating for CLRB (55). This means that NXTC’s stock grew somewhat faster than CLRB’s over the last 12 months.

NXTC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CLRB (100). This means that NXTC’s stock grew similarly to CLRB’s over the last 12 months.

NXTC's SMR Rating (100) in the Biotechnology industry is in the same range as CLRB (100). This means that NXTC’s stock grew similarly to CLRB’s over the last 12 months.

NXTC's Price Growth Rating (65) in the Biotechnology industry is in the same range as CLRB (96). This means that NXTC’s stock grew similarly to CLRB’s over the last 12 months.

CLRB's P/E Growth Rating (78) in the Biotechnology industry is in the same range as NXTC (100). This means that CLRB’s stock grew similarly to NXTC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLRBNXTC
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
89%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 25 days ago
84%
Bullish Trend 17 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CLRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMZE9.370.26
+2.80%
Amaze Holdings Inc
SKLZ7.340.07
+0.96%
Skillz
NSA32.610.08
+0.25%
National Storage Affiliates Trust
KOF97.310.14
+0.14%
Coca-Cola FEMSA SAB DE CV
MTUS16.57-0.01
-0.06%
Metallus

CLRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLRB has been closely correlated with QTTB. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CLRB jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRB
1D Price
Change %
CLRB100%
N/A
QTTB - CLRB
73%
Closely correlated
N/A
ADCT - CLRB
40%
Loosely correlated
+1.79%
IBRX - CLRB
39%
Loosely correlated
+3.03%
ANAB - CLRB
36%
Loosely correlated
-0.54%
PRAX - CLRB
35%
Loosely correlated
+2.03%
More

NXTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NXTC has been loosely correlated with SRPT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if NXTC jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXTC
1D Price
Change %
NXTC100%
+1.75%
SRPT - NXTC
37%
Loosely correlated
+0.25%
ACET - NXTC
34%
Loosely correlated
-1.14%
MBIO - NXTC
27%
Poorly correlated
-4.03%
CLRB - NXTC
26%
Poorly correlated
N/A
OKYO - NXTC
26%
Poorly correlated
-4.47%
More